» Articles » PMID: 32765703

MicroRNA-27a Inhibits Trophoblast Cell Migration and Invasion by Targeting SMAD2: Potential Role in Preeclampsia

Overview
Journal Exp Ther Med
Specialty Pathology
Date 2020 Aug 9
PMID 32765703
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

Preeclampsia (PE) is a severe idiopathic obstetric complication that occurs worldwide. Insufficient trophoblast invasion is a characteristic of the pathogenesis of PE. MicroRNA-27a (miR-27a) has been reported to be highly expressed in PE placentas. The aim of the present study was to investigate the role and underlying mechanisms of miR-27a in the pathogenesis of PE. The expression level of miR-27a was evaluated in the placenta and serum from patients with PE and healthy pregnant women. Cell Counting Kit-8 and flow cytometry assays were performed to detect human HTR-8/SVneo trophoblast proliferation and apoptosis after miR-27a overexpression or inhibition. In addition, Transwell assays were used to measure cell migration and invasion. A luciferase reporter assay was performed to determine the interaction between miR-27a and SMAD2. The present results suggested that miR-27a expression level was significantly increased in PE placentas and serum. In addition, miR-27a overexpression suppressed cell migratory and invasive abilities, impaired proliferation and promoted apoptosis in human trophoblasts. It was demonstrated that miR-27a may target SMAD and contribute to trophoblast invasion. Collectively, the results of the present study suggested that miR-27a inhibited trophoblast cell migration and invasion by targeting SMAD2, thus presenting a promising therapeutic target for PE.

Citing Articles

Vascular Endothelial Growth Factor Receptor 2: Molecular Mechanism and Therapeutic Potential in Preeclampsia Comorbidity with Human Immunodeficiency Virus and Severe Acute Respiratory Syndrome Coronavirus 2 Infections.

Abel T, Moodley J, Khaliq O, Naicker T Int J Mol Sci. 2022; 23(22).

PMID: 36430232 PMC: 9691176. DOI: 10.3390/ijms232213752.


Micro-RNAs in Human Placenta: Tiny Molecules, Immense Power.

Jin M, Xu Q, Li J, Xu S, Tang C Molecules. 2022; 27(18).

PMID: 36144676 PMC: 9501247. DOI: 10.3390/molecules27185943.


A blood-based miRNA signature for early non-invasive diagnosis of preeclampsia.

Bao S, Zhou T, Yan C, Bao J, Yang F, Chao S BMC Med. 2022; 20(1):303.

PMID: 36096786 PMC: 9469544. DOI: 10.1186/s12916-022-02495-x.


Preeclamptic Women Have Disrupted Placental microRNA Expression at the Time of Preeclampsia Diagnosis: Meta-Analysis.

Cirkovic A, Stanisavljevic D, Milin-Lazovic J, Rajovic N, Pavlovic V, Milicevic O Front Bioeng Biotechnol. 2022; 9:782845.

PMID: 35004644 PMC: 8740308. DOI: 10.3389/fbioe.2021.782845.


Increased FUN14 domain containing 1 (FUNDC1) ubiquitination level inhibits mitophagy and alleviates the injury in hypoxia-induced trophoblast cells.

Chen G, Chen L, Huang Y, Zhu X, Yu Y Bioengineered. 2021; 13(2):3620-3633.

PMID: 34699308 PMC: 8974051. DOI: 10.1080/21655979.2021.1997132.

References
1.
Kawamoto K, Pahuja A, Hering B, Bansal-Pakala P . Transforming growth factor beta 1 (TGF-beta1) and rapamycin synergize to effectively suppress human T cell responses via upregulation of FoxP3+ Tregs. Transpl Immunol. 2010; 23(1-2):28-33. DOI: 10.1016/j.trim.2010.03.004. View

2.
Yang S, Li H, Ge Q, Guo L, Chen F . Deregulated microRNA species in the plasma and placenta of patients with preeclampsia. Mol Med Rep. 2015; 12(1):527-34. DOI: 10.3892/mmr.2015.3414. View

3.
Katz L, Likhter M, Jogunoori W, Belkin M, Ohshiro K, Mishra L . TGF-β signaling in liver and gastrointestinal cancers. Cancer Lett. 2016; 379(2):166-72. PMC: 5107316. DOI: 10.1016/j.canlet.2016.03.033. View

4.
Ghulmiyyah L, Sibai B . Maternal mortality from preeclampsia/eclampsia. Semin Perinatol. 2012; 36(1):56-9. DOI: 10.1053/j.semperi.2011.09.011. View

5.
Vaiman D . Genes, epigenetics and miRNA regulation in the placenta. Placenta. 2017; 52:127-133. DOI: 10.1016/j.placenta.2016.12.026. View